India launches a single-window portal for medical devices management.

National

Finance Minister Nirmala Sitharaman had previously announced the creation of an investment clearance cell (ICC) during her Budget speech on February 1, 2020. The proposed ICC, now developed as the NSWS, enables investors to identify, apply, track, and obtain the necessary approvals before starting any business operations in India, eliminating the need for investors to visit multiple IT platforms and authorities, the Central Drugs Standard Control Organisation (CDSCO) notice read.


      Rajeev Raghuvanshi, drugs controller general of India, said the NSWS has been established as a “genuine single-window system

      which acts as a one-stop shop for all the approvals required by the investor and facilitates ease of doing business”.

      Business Standard has a copy of the document.

 

     


          ____________________________